First premature-ejaculation drug shows promise-JNJ

WASHINGTON (Reuters) - The first drug formulated to treat premature ejaculation works to delay climax and also increases reported satisfaction, developers said on Monday.

ADVERTISEMENT

A phase III clinical trial of 2,614 men showed the drug provided “significant improvements in sexual function, including ejaculatory control, satisfaction with sexual intercourse for men and their partners, and increases in intravaginal ejaculatory latency time,” Ortho Urology, a unit of Ortho-McNeil Pharmaceutical Inc., said in a statement.

The drug, called dapoxetine, is being co-developed by Mountain View, California-based Alza Corp. and Johnson & Johnson Pharmaceutical Services, LLC . Ortho-McNeil Pharmaceutical will market the drug in the United States if it receives U.S. Food and Drug Administration approval.

You need to provide a link to the article instead of just copy and paste, please.

Here’s the link:

Thanks sm!

You’re welcome. Good thing you asked for the link as the article has expanded since I copied/pasted it initially.